Trial intelligence / Profile preview

Topical Melatonin for Palatal Wound Healing

NCT05122130Phase 2Unknown

Start
Nov 2021
Primary completion
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in surgical wound comparing Melatonin group with Placebo group (2 arms). Primary endpoint: Palatal wound healing at 14 days. Status: unknown.

02

Drugs

melatonin
03

Conditions

surgical wound

Beyond the preview

Go deeper on NCT05122130.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05122130.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call